Incyte (INCY) EBIT Margin (2010 - 2026)
Incyte (INCY) recorded EBIT Margin of 41.69% in Q2 2026, down 1.94 percentage points from 43.63% a year earlier but up 18.03 percentage points from the prior quarter.
Powered by 
Analysis
Incyte (INCY) EBIT Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Incyte's EBIT Margin came in at 30.56% as of Jun 30, 2026, up 4.76 percentage points year-over-year; for FY2025, it was 29.46%, up 28.02 percentage points from FY2024.
- Annual EBIT Margin has a five-year change of +39.35 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at 1.45% in FY2024 (-15.34 pp), 16.79% in FY2023 (-0.28 pp), 17.07% in FY2022 (-2.55 pp) and 19.62% in FY2021 (+29.50 pp).
- Quarterly EBIT Margin has ranged from -45.81% in Q2 2024 to 43.63% in Q2 2025 over the past five years.
- On a year-over-year basis, EBIT Margin rose in five of the last eight quarters, with an average year-over-year change of +14.21 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 89.44 percentage points in Q2 2025, against a drop of 66.11 percentage points in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 23.66% (Q1 2026), 22.29% (Q4 2025) and 32.47% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn | 41.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.69% |
| Mar 31, 2026 | 23.66% |
| Dec 31, 2025 | 22.29% |
| Sep 30, 2025 | 32.47% |
| Jun 30, 2025 | 43.63% |
| Mar 31, 2025 | 19.49% |
| Dec 31, 2024 | 25.58% |
| Sep 30, 2024 | 12.84% |
| Jun 30, 2024 | -45.81% |
| Mar 31, 2024 | 10.43% |
| Dec 31, 2023 | 18.48% |
| Sep 30, 2023 | 23.36% |
| Jun 30, 2023 | 20.30% |
| Mar 31, 2023 | 3.06% |
| Dec 31, 2022 | 7.56% |
| Sep 30, 2022 | 16.81% |
| Jun 30, 2022 | 27.92% |
| Mar 31, 2022 | 15.89% |
| Dec 31, 2021 | 12.83% |
| Sep 30, 2021 | 28.96% |
API Access
Incyte EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();